Kuros Biosciences AG (0RHR.L)
CHF 20.55
(1.23%)
CHF 20.55
(1.23%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 19.19 Million CHF | 36.26% |
| 2022 | 14.08 Million CHF | -1.91% |
| 2021 | 14.36 Million CHF | 47.09% |
| 2020 | 9.76 Million CHF | -2.34% |
| 2019 | 9.99 Million CHF | 7.06% |
| 2018 | 9.33 Million CHF | -27.84% |
| 2017 | 12.94 Million CHF | 137.62% |
| 2016 | 5.44 Million CHF | 110.27% |
| 2015 | 2.59 Million CHF | -94.09% |
| 2014 | 43.85 Million CHF | 20.89% |
| 2013 | 36.27 Million CHF | 78.14% |
| 2012 | 20.36 Million CHF | -52.08% |
| 2011 | 42.49 Million CHF | -10.5% |
| 2010 | 47.47 Million CHF | -21.48% |
| 2009 | 60.46 Million CHF | -23.37% |
| 2008 | 78.89 Million CHF | 14.13% |
| 2007 | 69.12 Million CHF | 500.46% |
| 2006 | 11.51 Million CHF | 37.33% |
| 2005 | 8.38 Million CHF | 2.34% |
| 2004 | 8.19 Million CHF | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 17.12 Million CHF | 0.0% |
| 2023 Q1 | 14.29 Million CHF | 1.49% |
| 2023 Q2 | 14.29 Million CHF | -0.01% |
| 2023 Q4 | 19.19 Million CHF | 30.11% |
| 2023 FY | 19.19 Million CHF | 36.26% |
| 2023 Q3 | 14.75 Million CHF | 3.2% |
| 2022 Q3 | 14.08 Million CHF | -6.5% |
| 2022 Q2 | 15.06 Million CHF | 0.0% |
| 2022 Q1 | 15.06 Million CHF | 4.92% |
| 2022 FY | 14.08 Million CHF | -1.91% |
| 2022 Q4 | 14.08 Million CHF | 0.0% |
| 2021 Q2 | 8.53 Million CHF | 0.0% |
| 2021 FY | 14.36 Million CHF | 47.09% |
| 2021 Q4 | 14.36 Million CHF | 0.0% |
| 2021 Q1 | 8.53 Million CHF | -12.57% |
| 2021 Q3 | 14.36 Million CHF | 68.23% |
| 2020 Q3 | 9.76 Million CHF | 11.9% |
| 2020 Q4 | 9.76 Million CHF | 0.0% |
| 2020 FY | 9.76 Million CHF | -2.34% |
| 2020 Q2 | 8.72 Million CHF | 0.0% |
| 2020 Q1 | 8.72 Million CHF | -12.72% |
| 2019 Q1 | 9.94 Million CHF | 6.5% |
| 2019 Q3 | 9.99 Million CHF | 0.52% |
| 2019 Q2 | 9.94 Million CHF | 0.0% |
| 2019 FY | 9.99 Million CHF | 7.06% |
| 2019 Q4 | 9.99 Million CHF | 0.0% |
| 2018 Q2 | 10.26 Million CHF | 247.01% |
| 2018 Q3 | 4.04 Million CHF | -60.65% |
| 2018 Q1 | 2.95 Million CHF | -77.13% |
| 2018 FY | 9.33 Million CHF | -27.84% |
| 2018 Q4 | 9.33 Million CHF | 131.14% |
| 2017 Q3 | 4.65 Million CHF | -64.85% |
| 2017 FY | 12.94 Million CHF | 137.62% |
| 2017 Q1 | 4.87 Million CHF | -10.58% |
| 2017 Q4 | 12.94 Million CHF | 177.94% |
| 2017 Q2 | 13.24 Million CHF | 172.01% |
| 2016 Q3 | 3.26 Million CHF | -42.89% |
| 2016 FY | 5.44 Million CHF | 110.27% |
| 2016 Q2 | 5.71 Million CHF | 148.13% |
| 2016 Q4 | 5.44 Million CHF | 66.8% |
| 2016 Q1 | 2.3 Million CHF | -11.04% |
| 2015 Q3 | 5.14 Million CHF | 229.05% |
| 2015 FY | 2.59 Million CHF | -94.09% |
| 2015 Q2 | 1.56 Million CHF | 0.0% |
| 2015 Q4 | 2.59 Million CHF | -49.64% |
| 2014 Q4 | 43.85 Million CHF | 0.0% |
| 2014 FY | 43.85 Million CHF | 20.89% |
| 2014 Q2 | 37.55 Million CHF | 0.0% |
| 2013 Q2 | 22.84 Million CHF | 9.83% |
| 2013 Q3 | 27.13 Million CHF | 18.76% |
| 2013 Q1 | 20.8 Million CHF | 2.16% |
| 2013 FY | 36.27 Million CHF | 78.14% |
| 2013 Q4 | 36.27 Million CHF | 33.68% |
| 2012 Q4 | 20.36 Million CHF | -7.31% |
| 2012 Q1 | 16.51 Million CHF | -61.13% |
| 2012 Q2 | 18.55 Million CHF | 12.32% |
| 2012 Q3 | 21.96 Million CHF | 18.43% |
| 2012 FY | 20.36 Million CHF | -52.08% |
| 2011 Q2 | 46.31 Million CHF | -1.75% |
| 2011 Q3 | 47.82 Million CHF | 3.25% |
| 2011 Q4 | 42.49 Million CHF | -11.14% |
| 2011 FY | 42.49 Million CHF | -10.5% |
| 2011 Q1 | 47.14 Million CHF | -0.7% |
| 2010 Q1 | 52.4 Million CHF | -13.32% |
| 2010 FY | 47.47 Million CHF | -21.48% |
| 2010 Q4 | 47.47 Million CHF | 1.82% |
| 2010 Q3 | 46.62 Million CHF | 2.72% |
| 2010 Q2 | 45.39 Million CHF | -13.39% |
| 2009 Q4 | 60.46 Million CHF | 0.0% |
| 2009 FY | 60.46 Million CHF | -23.37% |
| 2008 FY | 78.89 Million CHF | 14.13% |
| 2007 FY | 69.12 Million CHF | 500.46% |
| 2006 FY | 11.51 Million CHF | 37.33% |
| 2005 FY | 8.38 Million CHF | 2.34% |
| 2004 FY | 8.19 Million CHF | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|